What is the Projected CAGR value of the Oligonucleotide Therapy Market?
Oligonucleotide Therapy Market is expected to grow at a CAGR of 15.80% during the forecast period 2024-2031
Who are the key players in Oligonucleotide Therapy Market ?
Major players are Kastle Therapeutics, Sarepta Therapeutics, Pfizer Inc., InteRNA Technologies B.V, Santaris, Akcea Therapeutics, Miragen Therapeuutics Inc, Alnylam Pharmaceuticals Inc, Biogen Inc and Ionis Pharmaceuticals Inc.